p16(INK4a) promoter is hypermethylated at a high frequency in esophageal adenocarcinomas

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2619-2622

  Wong, David J ^a   Barrett, Michael T ^a   Stöger, Reinhard ^a   Emond, Mary J ^b   Reid, Brian J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; CARRIER PROTEIN; PROTEIN P16INK4A;

ARTICLE; BARRETT ESOPHAGUS; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; METHYLATION; PRECANCER; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CELL CULTURE; CHROMOSOME 9; CHROMOSOME DELETION; DNA METHYLATION; ESOPHAGUS TUMOR; GENETICS; HETEROZYGOTE; PROMOTER REGION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARRIER PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0030612290     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
2. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
3. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germ-line mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
4. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
5. Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265: 415-416, 1994.
6. Zhou, X., Tarmin, L., Yin, J., Jiang, H. Y., Suzuki, H., Rhyu, M. G., Abraham, J. M., and Meltzer, S. J. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9: 3737-3741, 1994.
7. Jen, J., Harper, W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Wilson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
8. INK4B. Cancer Res., 56: 722-727, 1996.
9. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G., and Kamb, A. Complex structure and regulation of the p16 (MTS1) locus. Cancer Res., 55: 2988-2994, 1995.
10. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of tumour suppressor p16/CDKN2/MTS1 in human cancers. Nut. Med., 1: 686-692, 1995.
11. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
12. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
13. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
14. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. I., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
15. Phillips, R. W., and Wong, R. K. H. Barrett's esophagus: natural history, incidence, etiology, and complications. Gastroenterol. Clin. North Am., 20: 791-816, 1991.
16. Burrett. M. T., Sanchez, C. A., Galipeau, P. C., Neshat, K., Emond. M., and Reid, B. J. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene, 13: 1867-1873, 1996.
17. Reid, B. J., Haggitt, R. C., Rubin, C. E., and Rabinovitch, P. S. Barrett's esophagus: correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology, 93: 1-11, 1987.
18. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
19. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylalion status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
20. Zhang, L., Cui, X., Schmitt, K., Hubert, R., Navidi, W., and Arnheim, N. Whole genome amplification from a single cell: implications for genetic analysis. Proc. Natl. Acad. Sci. USA, 89: 5847-5851, 1992.
21. Barrett, M. T., Reid, B. J., and Joslyn, G. Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res., 23: 3488-3492, 1995.
22. McDonald, L. E., and Kay, G. F. Methylation analysis using bisulfite genomic sequencing: application to small numbers of intact cells. Biotechniques, 22: 272-274, 1997.
23. Costello, J. F., Berger, M. S., Huang, H-J. S., and Cavenee, W. K. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res., 56: 2405-2410, 1996.
24. Wiest, J. S., Franklin, W. A., Otstot, J. T., Forbey, K., Varella-Garcia, M., Rao, K., Drabkin, H., Gemmill, R., Ahrent, S., Sidransky, D., Saccomanno, G., Fountain, J. W., and Anderson, M. W. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res., 57: 1-6, 1997.
25. Stone, S., Dayananth, P., Jiang, P., Weaver-Geldhous, J. M., Tavtigian, S. V., Cannon-Albright, L., and Kamb, A. Genomic structure, expression, and mutational analysis of the p15 (MTS2) gene. Oncogene, 11: 987-991, 1995.
26. Reid, B. J., Barrett, M. T., Galipeau, P. C, Sanchez, C. A., Neshat, K., Cowan, D. S., and Levine, D. S. Barrett's esophagus: ordering the events that lead to cancer. Eur. J. Cancer Prev., 5(Suppl. 2): 57-65, 1996.
27. Barrett, M. T., Schutte, M., Kern, S. E., and Reid, B. J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res., 56: 4351-4353, 1996.